NCT06031337View on ClinicalTrials.gov

Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 3, 2023

Primary Completion Date

November 22, 2023

Study Completion Date

December 1, 2023

Conditions

Oral CancerOral Squamous Cell Carcinoma

Interventions

DIAGNOSTIC_TEST

ELISA

quantitative determination of salivary SOX7 using an Enzyme Linked Immunosorbent assay (ELISA) kit based on the sandwich principle according to the manufacturer's protocol.

Trial Locations (1)

Unknown

Fayoum University, Al Fayyum

All Listed Sponsors

lead

Fayoum University

OTHER

NCT06031337 - Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study | Biotech Hunter | Biotech Hunter